Inhibition of FAK, as observed in the study of phosphorylated kinases in PDAC, shows synergistic effects with nab-paclitaxel to reduce tumor growth and appears to be a promising potential treatment option [156]. The gene discussed is PTK2; the disease is neoplasm.